The invention relates to deuterated catecholamine derivatives and medicamentscomprising said compounds. The invention further relates to the use ofdeuterated catecholamine derivatives, the pharmacologically-acceptable saltsthereof and pharmaceutical compositions containing said compounds, also incombination with enzyme inhibitors, for the treatment of dopamine deficiencydiseases or diseases relating to disturbed tyrosine transport or disturbedtyrosine decarboxylase and other diseases.